AC Immune (ACIU) Assets Average (2016 - 2025)

AC Immune (ACIU) has 9 years of Assets Average data on file, last reported at $203.8 million in Q4 2025.

• Quarterly Assets Average fell 25.29% year-over-year to $203.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $203.8 million (down 25.29% YoY) and the FY2025 annual result came in at $224.8 million, down 4.27% from the prior year.
• Assets Average fell to $203.8 million in Q4 2025 per ACIU's latest filing, from $222.1 million in the prior quarter.
• Across five years, Assets Average topped out at $272.8 million in Q4 2024 and bottomed at $226507.9 in Q3 2021.
• The 5-year median for Assets Average is $203.3 million (2025), against an average of $190.1 million.
• The widest annual swing landed in 2021, when Assets Average plunged 99.92%; it then soared 99172.58% in 2022.
• Tracing ACIU's Assets Average over 5 years: stood at $141.9 million in 2021, then soared by 43.03% to $202.9 million in 2022, then decreased by 9.33% to $184.0 million in 2023, then soared by 48.24% to $272.8 million in 2024, then decreased by 25.29% to $203.8 million in 2025.
• Per Business Quant, the three latest ACIU Assets Average figures stand at $203.8 million (Q4 2025), $222.1 million (Q3 2025), and $232.3 million (Q2 2025).

Peer Comparison